Literature DB >> 26988989

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis.

Lidia Rodriguez Calleja1, Camille Jacques1, François Lamoureux1, Marc Baud'huin2, Marta Tellez Gabriel1, Thibaut Quillard1, Debashish Sahay3, Pierre Perrot2, Jerome Amiaud1, Celine Charrier1, Regis Brion1, Fernando Lecanda4, Franck Verrecchia1, Dominique Heymann2, Leif W Ellisen5, Benjamin Ory6.   

Abstract

Primary cancer cell dissemination is a key event during the metastatic cascade, but context-specific determinants of this process remain largely undefined. Multiple reports have suggested that the p53 (TP53) family member p63 (TP63) plays an antimetastatic role through its minor epithelial isoform containing the N-terminal transactivation domain (TAp63). However, the role and contribution of the major p63 isoform lacking this domain, ΔNp63α, remain largely undefined. Here, we report a distinct and TAp63-independent mechanism by which ΔNp63α-expressing cells within a TGFβ-rich microenvironment become positively selected for metastatic dissemination. Orthotopic transplantation of ΔNp63α-expressing human osteosarcoma cells into athymic mice resulted in larger and more frequent lung metastases than transplantation of control cells. Mechanistic investigations revealed that ΔNp63α repressed miR-527 and miR-665, leading to the upregulation of two TGFβ effectors, SMAD4 and TβRII (TGFBR2). Furthermore, we provide evidence that this mechanism reflects a fundamental role for ΔNp63α in the normal wound-healing response. We show that ΔNp63α-mediated repression of miR-527/665 controls a TGFβ-dependent signaling node that switches off antimigratory miR-198 by suppressing the expression of the regulatory factor, KSRP (KHSRP). Collectively, these findings reveal that a novel miRNA network involved in the regulation of physiologic wound-healing responses is hijacked and suppressed by tumor cells to promote metastatic dissemination. Cancer Res; 76(11); 3236-51. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26988989      PMCID: PMC4891241          DOI: 10.1158/0008-5472.CAN-15-2317

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.

Authors:  Maurice Phillip DeYoung; Cory M Johannessen; Chee-Onn Leong; William Faquin; James W Rocco; Leif W Ellisen
Journal:  Cancer Res       Date:  2006-10-01       Impact factor: 12.701

2.  Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene.

Authors:  S Dennler; S Itoh; D Vivien; P ten Dijke; S Huet; J M Gauthier
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

Review 3.  Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.

Authors:  Wende Kozlow; Theresa A Guise
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

4.  A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.

Authors:  Kim J Png; Nils Halberg; Mitsukuni Yoshida; Sohail F Tavazoie
Journal:  Nature       Date:  2011-12-14       Impact factor: 49.962

Review 5.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 6.  p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.

Authors:  G Melino
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

7.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

8.  The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs.

Authors:  Michele Trabucchi; Paola Briata; Mariaflor Garcia-Mayoral; Astrid D Haase; Witold Filipowicz; Andres Ramos; Roberto Gherzi; Michael G Rosenfeld
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

9.  Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.

Authors:  Paola Tucci; Massimiliano Agostini; Francesca Grespi; Elke K Markert; Alessandro Terrinoni; Karen H Vousden; Patricia A J Muller; Volker Dötsch; Sebastian Kehrloesser; Berna S Sayan; Giuseppe Giaccone; Scott W Lowe; Nozomi Takahashi; Peter Vandenabeele; Richard A Knight; Arnold J Levine; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  26 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.

Authors:  Amy C Gross; Hakan Cam; Doris A Phelps; Amanda J Saraf; Hemant K Bid; Maren Cam; Cheryl A London; Sarah A Winget; Michael A Arnold; Laura Brandolini; Xiaokui Mo; John M Hinckley; Peter J Houghton; Ryan D Roberts
Journal:  JCI Insight       Date:  2018-08-23

3.  ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.

Authors:  Linshan Hu; Shan Liang; Hu Chen; Tao Lv; Junfeng Wu; Deshi Chen; Min Wu; Shengnan Sun; Haibo Zhang; Han You; Hongbin Ji; Yujun Zhang; Johann Bergholz; Zhi-Xiong Jim Xiao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-03       Impact factor: 11.205

Review 4.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

Review 5.  Osteosarcoma: Accelerating Progress Makes for a Hopeful Future.

Authors:  Amanda J Saraf; Joelle M Fenger; Ryan D Roberts
Journal:  Front Oncol       Date:  2018-01-26       Impact factor: 6.244

6.  KH-type splicing regulatory protein is involved in esophageal squamous cell carcinoma progression.

Authors:  Yuji Fujita; Kiyoshi Masuda; Junichi Hamada; Katsutoshi Shoda; Takuya Naruto; Satoshi Hamada; Yuko Miyakami; Tomohiro Kohmoto; Miki Watanabe; Rizu Takahashi; Shoichiro Tange; Masako Saito; Yasusei Kudo; Hitoshi Fujiwara; Daisuke Ichikawa; Akira Tangoku; Eigo Otsuji; Issei Imoto
Journal:  Oncotarget       Date:  2017-09-15

7.  Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.

Authors:  Zehang Zhuang; Nan Xie; Jing Hu; Pei Yu; Cheng Wang; Xingxue Hu; Xiaozhe Han; Jinsong Hou; Hongzhang Huang; Xiqiang Liu
Journal:  Oncotarget       Date:  2017-03-28

Review 8.  ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition.

Authors:  Andrew J Stacy; Michael P Craig; Suraj Sakaram; Madhavi Kadakia
Journal:  Oncotarget       Date:  2017-01-10

9.  Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.

Authors:  Xing Bao; Tingting Ren; Yi Huang; Shidong Wang; Fan Zhang; Kuisheng Liu; Bingxin Zheng; Wei Guo
Journal:  J Exp Clin Cancer Res       Date:  2016-08-30

10.  A wound-healing program is hijacked to promote cancer metastasis.

Authors:  Leif W Ellisen
Journal:  J Exp Med       Date:  2017-09-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.